ECYT

ENDOCYTE INC Files SEC form 10-Q, Quarterly Report

moreView todays social media effects on ECYTView the latest stocks trending across Twitter. Click to view dashboardSee who Endocyte is hiring next, click here to view […]

Endocyte, Inc. (ECYT) in Focus: Stock Rises 5.6%

moreView todays social media effects on ECYTView the latest stocks trending across Twitter. Click to view dashboardSee who Endocyte is hiring next, click here to view […]

Endocyte Shares Sink on DSMB Recommendation

moreView todays social media effects on ECYTView the latest stocks trending across Twitter. Click to view dashboardSee who Endocyte is hiring next, click here to view […]

Today’s Dead Cat Bounce Stock: Endocyte (ECYT)

moreView todays social media effects on ECYTView the latest stocks trending across Twitter. Click to view dashboardSee who Endocyte is hiring next, click here to view […]

Endocyte’s CEO Discusses Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Michael Sherman Thanks, Ron. I won’t be going over the detailed financials, which are in the release from this morning. But I want to look a bit at the larger picture with Merck having responsibility for … moreView todays social media effects on ECYTView the latest stocks trending across Twitter. Click to view dashboardSee who Endocyte […]

Endocyte Announces Presentations at AACR Annual Meeting 2014

[GlobeNewswire] – WEST LAFAYETTE, Ind. — Endocyte, Inc. a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy in cancer … moreView todays social media effects on ECYTView the latest stocks trending across Twitter. Click to view dashboardSee who Endocyte is hiring next, click here to view […]

Big Pharma Failure = Biotech Takeover?

moreView todays social media effects on ECYTView the latest stocks trending across Twitter. Click to view dashboardSee who Endocyte is hiring next, click here to view […]

Endocyte, Inc. Prices Public Offering of Common Stock

[GlobeNewswire] – WEST LAFAYETTE, Ind. — Endocyte, Inc. announced the pricing of an underwritten public offering of 4,500,000 shares of its common stock at a price to the public of $21.00 per share. The gross proceeds … moreView todays social media effects on ECYTView the latest stocks trending across Twitter. Click to view dashboardSee who Endocyte is hiring next, click […]